Dyne Therapeutics (NASDAQ:DYN) shares fell 31.0% to $16.76 in premarket trading, compared with a previous close of $24.28. No official company announcement confirming a reason for the share-price movement had been identified at the time of writing, and the cause of the decline remains unclear.